The lack of BBB penetrating AT4 receptor agonists and antagonists has limited our understanding concerning the relative importance of brain AT1 and AT4 receptor subtypes in the etiology and treatment of dementias, stroke, and related memory dysfunctions. The gene discussed is AGTR1; the disease is stroke disorder.